Copy of Newspaper Publication

November 04, 2026 To, To, Listing/Compliance Department Listing/Compliance Department BSE Limited National Stock Exchange of India Limited Phiroze Jeejeebhoy Towers, Exchange Plaza, Plot No. C/1, Dalal Street, G-Block, Bandra-Kurla Complex, Mumbai – 400001 Bandra (E), Mumbai – 400051 BSE CODE – 543998 NSE Symbol: VALIANTLAB Dear Sir/Madam, Subject: Newspaper Publication of Financial Results for the Quarter and Half Year ended September 30, 2026. Ref: Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Please find enclosed herewith copies of the newspaper publication of the Standalone and Consolidated Audited Financial Results for the quarter and half year ended September 30, 2026, published in below mentioned newspapers: 1) Financial Express (in English) on November 04, 2026. 2) Mumbai Lakshadeep (in Marathi) on November 04, 2026. This intimation is also being uploaded on the Company’s website at www.valiantlabs.in We request you to take the same on record. Thanking you, Yours faithfully, For Valiant Laboratories Limited Akshay Gangurde Company Secretary & Compliance Officer Encl: As above www.valiantlabs.in | CIN : L24299MH2021PLC365904 Registered Office: 104, Udyog Kshetra, Mulund-Goregaon Link Road, Mulund (W), Mumbai - 400080. Corporate Office: 701-A, 7th Floor, Tower-B, Embassy 247, L.B.S. Road, Vikhroli (West), Mumbai-400083. T: 022-49717221/49712001/49717220 | E: investor@valiantlabs.in WWW FNANCIALEXPRESS COM WEDNESDAY, NOVEMBb,E 2R02 6 FINANCIAL EXPRESS 39 ®e0¢. . VALIANT LABORATORIES LIMITED S CIN: L24299MH2021PLC365904 Registered Office: 104, Udyog Kshetra, Mulund-Goregaon Link Road, Mulund (W), Mumbai - 400080 | Tel No.: 022-49712001 / 49717220 /49717221 nvestor@valiantlabs. Website: www.valiantlabs.in STATEMENT OF STANDALONE AND CONSOLIDATED AUDITED FINANCIAL RESULTS FOR THE QUARTER AND HALF Y R ENDED SEPT Stancalore N at 3 Quarter Endad Half Year Erded Quarter Ended | Half Yoar Ended e, Particulars 30092426 |30.09.2025 |30.09.2026 | 30.09.2025 | $0.092028 | 31.092025 | 30.09.2026 | 30.09.2025 | (Puoted) | [Audites) | {Ancited) | {Auciteq) | {Auched) | Audied) } WAudred) | (Audied) 1.| Total Income from Dperations (Net) 706452 | 406034 | 1471188 | 885119 [11,608.75 | 4,700.84 | 23,300.28 | 945466 2.! Net Profit! (Less) for the period befcre Tax 180.29 2579 | 146209 | 27037 63.88 2765 | 268592 | 27252 3.| Exceptional items - - - - - - - - 4./ Net Profit/ (Less) for the period aftes Tax 14544 1667 108332 | 198 414 2001 | 215163 | 20210 5.| Total Comprahensive Incoma for the perod (Comprising Profit/ (Less) and Other Comgrehensive Income for the pericd) 148,02 1749 | 109530 | 19908 4264 2023 | 2,152.94 | 20232 5., Paid-up Equity Shere Capital 543125 | 5431.25 | 543125 | 543125 | 543125 | 543125 | 543125 | 543125 7.| Resenve excluding Revaluztion Reserves & per Batance Sheet of previous Accounting Year 8.| Eaming per share (in %) | {8) Basic 027 0.03 2m 0.3 0.08 0.04 396 037 (b} Diuted 02 0.3 20 0.3 0.08 004 386 | o037 Notes: 1)The above is an extract of detaied format of Financial Resuls filed wih Stock Exchanges under Reguition 33 of the SEB (Listing Obiligations and Disclosure Requirements) Reguiations, 2015. The full format of the Financia! Resulis ar2 avaliable on the websites of the Stock Exchangels), vz.. www.bseindia.com| and waw.nseindia.com aod website of the Company 0n wiw.vakantabs.in 2) Tre above Financial Resulls for the quarter ended Sept 30, 2025 hare been reviewed by the Audit Commitee and épproved by the Board of Dirsctors in heir meetheitd nongNo v 12, 2026, 3) The Financal Resuls have been pepared 1 accordance with Indian Accourting Stardarts ("IndAS") preserbed under Secton 133f (he CenpanieAsc t 2013 reads with relavant nies thareenda:andin farms of Raguiadon 33 of e SEB! LUisting Oniigations and Discosure Requiraments) Reguiations. 2015 - For Valiant Laboratories lels:ld Santosh Vora Date: November 02, 2026 Managing Director Place: Mumbal E DIN: 07633923 @ e, . ov i 2e3 sut i o.8 SETCAUkEs A= T A TATHES AT T4 2 ST Y0 3 YT 3 0% FtauiigEa Fratera: 2 0%, JAM &, TYS-Tema forn 1%, TS wfeEE-v000¢0. ) ki :03R-¥86%200% /¥RI5215330 / ¥R1s257 2%, e Investor@valiantiabs.in; zraremsz: www.valiantiabs.in = T fermRt T il TP WUy - i 30.08.35 | $9.04.24 [ §0.04.2¢ [30.0%.24 [ 30.04.35] Jo.0834[ J0.083¢ | e g o (Pr) 728452 | 468334 | 14711.89] 985119 [11688.75 | 4,706.84 | 23,303.28 | 9,454.66 2| v v o v (o) 18828 2579 | 146209( 27037 | 6688 | 2785 | 268592 | 27252 3| s - - - - - - - - ¢ | arire R Frog s/ (o) 14544 1667 | 100332 19824 [ 4134 | 2001 [ 215183 | 20210 | e T e T (ewtare s / (i) (i) s e e v (o)) 148.02 1749 [ 109580( 19906 | 4264 | 2023 | 215294 | 20232 & | treom drwees iy S 543125 | 543125 543125( 543125 | 543125 | 543125 | 543125 | 543125 o | s o g ¢ | e o (v50/-) 2 2 2 2 : * 3 e o = -o7 0.03 201 0.36 0.08 004 396 0.37 = g -0 003 201 036 008 004 39 037 #ta: 1 et (sfee ooy Sfow framiers S ) ey 2004 = P 93 o e i e T T s frvts Framds i o e s, fevter Fremefes et v S i core wWww bseindia.com = www.nseindia com s weires W valiantiabs in Semmite e L e S S e e e e e Ly e e e S i T e S e e e e o St e T 20 T 33 s o e e e (e s s fmre S L s e e e S e e T o s ffaefm it/ - | e zd T S ferian: 03 e, 203t STonii 39 23